NCT02323347

Brief Summary

At which deleterious cut off value of progesterone on day of HCG (P-hCG) in our IVF program should fresh embryo transfer (ET) be cancelled?

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,901

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2009

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 23, 2014

Completed
Last Updated

December 23, 2014

Status Verified

December 1, 2014

Enrollment Period

5.2 years

First QC Date

December 11, 2014

Last Update Submit

December 22, 2014

Conditions

ProgesteroneFertilization in VitroInfertilityPregnancy

Outcome Measures

Primary Outcomes (1)

  • Clinical Pregnancy

    6 weeks after embryo transfer procedure

Interventions

ProgesteroneOTHER

Progesterone level

Eligibility Criteria

Age18 Years - 49 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women undergoing IVF-ICSI ad fresh embryo transfer

You may qualify if:

  • Fresh embryo transfer
  • Progesterone value on day HCG (Human choriogonadotrophin hormone)

You may not qualify if:

  • Clinical indication for delaying embryo transfer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Martinez F, Rodriguez I, Devesa M, Buxaderas R, Gomez MJ, Coroleu B. Should progesterone on the human chorionic gonadotropin day still be measured? Fertil Steril. 2016 Jan;105(1):86-92. doi: 10.1016/j.fertnstert.2015.09.008. Epub 2015 Oct 9.

    PMID: 26453983DERIVED

MeSH Terms

Conditions

Infertility

Interventions

Progesterone

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

PregnenedionesPregnenesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsCorpus Luteum HormonesGonadal HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsProgesterone CongenersGonadal Steroid Hormones

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

December 11, 2014

First Posted

December 23, 2014

Study Start

January 1, 2009

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

December 23, 2014

Record last verified: 2014-12